Company Search:
Advanced Search
Sponsored Links
ABL Bio Inc Company Snapshot
ABL Bio Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares ABL Bio Inc with three other companies in this sector in KOREA (SOUTH) : NKMax Co Ltd (2020 sales of 10.37 billion Korean Won [US$9.27 million] of which 33% was NK Vue KIT), Kang Stem Biotech Co Ltd (9.14 billion Korean Won [US$8.17 million] of which 84% was Nonclinical CRO), and Pangen Biotech Inc (6.19 billion Korean Won [US$5.53 million] of which 57% was EPO).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ABL Bio Inc
  Stock Performance Chart for ABL Bio Inc
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 21,300
(Figures in Korean Won )
1 Week 4.7%   13 Weeks 3.1%  
4 Weeks -1.4%   52 Weeks -27.7%  
ABL Bio Inc Key Data:
  Ticker: 298380 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 8,104,203,457
(Year Ending Jan 2021).
Employees: 89
  Currency: Korean Won Market Cap: 1,003,725,757,500
  Fiscal Yr Ends: December Shares Outstanding: 47,123,275
  Share Type: Common Closely Held Shares: 14,859,125
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.